Arcus Biosciences (RCUS, $14.98) is predicted by A.I.dvisor to decline by to $14.68 or more within the next week. Following its losing streak extending for a consecutive week, RCUS is expected to continue dropping based on similar cases which trended down, making the odds of a Downtrend continuation